52 related articles for article (PubMed ID: 1624085)
1. Effect of histamine-2 receptor antagonists on blood alcohol levels: a meta-analysis.
Weinberg DS; Burnham D; Berlin JA
J Gen Intern Med; 1998 Sep; 13(9):594-9. PubMed ID: 9754514
[TBL] [Abstract][Full Text] [Related]
2. Ranitidine Use and Incident Cancer in a Multinational Cohort.
You SC; Seo SI; Falconer T; Yanover C; Duarte-Salles T; Seager S; Posada JD; Shah NH; Nguyen PA; Kim Y; Hsu JC; Van Zandt M; Hsu MH; Lee HL; Ko H; Shin WG; Pratt N; Park RW; Reich CG; Suchard MA; Hripcsak G; Park CH; Prieto-Alhambra D
JAMA Netw Open; 2023 Sep; 6(9):e2333495. PubMed ID: 37725377
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
4. Does H2 receptor antagonist-resistant ulcer exist?--A review based on bioavailability in man.
Kawai K
Gastroenterol Jpn; 1992 Jun; 27(3):418-23. PubMed ID: 1624085
[TBL] [Abstract][Full Text] [Related]
5. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
6. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
7. A controlled comparison of continuous ranitidine and intermittent famotidine infusions on gastric pH.
Bachmann K; Sullivan TJ; Jauregui L
J Clin Pharmacol; 1993 Dec; 33(12):1219-24. PubMed ID: 7907348
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infection.
Komazawa Y; Adachi K; Mihara T; Ono M; Kawamura A; Fujishiro H; Kinoshita Y
J Gastroenterol Hepatol; 2003 Jun; 18(6):678-82. PubMed ID: 12753150
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine.
Adachi K; Komazawa Y; Mihara T; Azumi T; Fujisawa T; Katsube T; Furuta K; Kinoshita Y
J Gastroenterol Hepatol; 2005 Jul; 20(7):1012-5. PubMed ID: 15955208
[TBL] [Abstract][Full Text] [Related]
10. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.
Sharma BK; Walt RP; Pounder RE; Gomes MD; Wood EC; Logan LH
Gut; 1984 Sep; 25(9):957-64. PubMed ID: 6469081
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of ranitidine.
Roberts CJ
Clin Pharmacokinet; 1984; 9(3):211-21. PubMed ID: 6329583
[TBL] [Abstract][Full Text] [Related]
12. Ranitidine disposition in patients with renal impairment.
Meffin PJ; Grgurinovich N; Brooks PM; Miners JO; Cochran M; Stranks G
Br J Clin Pharmacol; 1983 Dec; 16(6):731-4. PubMed ID: 6318787
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacodynamics and pharmacokinetics of cimetidine and ranitidine.
Richards DA
J Clin Gastroenterol; 1983; 5 Suppl 1():81-90. PubMed ID: 6317740
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
